U.S. Pharmaceuticals & Biotech Breakout Stocks

Moderna

Market Cap: US$57.9b

A biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.

BioNTech

Market Cap: US$29.3b

Engages in the development and commercialization of immunotherapies in Germany.

Amylyx Pharmaceuticals

Market Cap: US$4.3b

A clinical-stage pharmaceutical company, engages in the discovery and development of treatment options for neurodegenerative diseases and endocrine conditions in the United States.

Maravai LifeSciences Holdings

Market Cap: US$2.2b

A life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America.

Xencor

Market Cap: US$2.1b

A clinical-stage biopharmaceutical company, focuses on the discovery and development of engineered antibodies for the treatment of cancer and autoimmune diseases.

Personalis

Market Cap: US$2.0b

Develops, markets, and sells advanced cancer genomic tests and services in the United States and internationally.

Immix Biopharma

Market Cap: US$977.2m

A clinical-stage biopharmaceutical company, engages in the development of chimeric antigen receptor cell therapy in light chain Amyloidosis and immune-mediated diseases in the United States and Australia.

Nuvectis Pharma

Market Cap: US$767.6m

A clinical-stage biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious conditions of unmet medical need in oncology.

OmniAb

Market Cap: US$629.5m

A biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada.

ProQR Therapeutics

Market Cap: US$330.2m

A clinical-stage biotechnology company, focuses on the discovery and development of novel therapeutic medicines.

AVITA Medical

Market Cap: US$311.1m

Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.

Journey Medical

Market Cap: US$218.7m

A commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.

Cypherpunk Technologies

Market Cap: US$153.0m

A privacy technology company, implements a digital asset strategy anchored by Zcash in the United States.

Marker Therapeutics

Market Cap: US$23.2m

A clinical-stage immuno-oncology company, develops and commercializes T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications in the United States.

BioVie

Market Cap: US$14.7m

A clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease in the United States.

Cardiac Biotech Solutions

Market Cap: US$6.5m

Through its subsidiaries, provides ambulatory non-invasive cardiac monitoring products and services in the United States and internationally.

International Stem Cell

Market Cap: US$4.0m

A clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally.

Emmaus Life Sciences

Market Cap: US$2.3m

A commercial-stage biopharmaceutical company, discovers, develops, markets, and sells treatments and therapies primarily for rare and orphan diseases in the United States and internationally.

Orgenesis

Market Cap: US$980.0k

A biotech company, focuses on cell and gene therapies in the United States.

PAO Group

Market Cap: US$573.1k

Focuses on alternative patient care treatments.

Neutra

Market Cap: US$304.3k

Researches, develops, and provides hemp-derived products in the nutraceutical space in the United States.

Cannonau

Market Cap: US$48.4k

Engages in the provision of cannabidiol based products.